Skip to main content

Table 4 Clearance reduction, artesunate/amodiaquine groups

From: Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999–2009

Country site Parasitaemia, geometric mean N Parasite reduction ratio (individual data)
   d1/d0 d2/d0 d3/d0 d7/d0
Burkina faso - Nanoro 2008 21,185 295 97.8% 100.0% 100.0% 100.0%
Cameroon 2006 24,129 110 97.0% 100.0% 100.0% 100.0%
Gabon - Fougamou 2008 21,117 80 98.6% 100.0% 100.0% 100.0%
Gabon 1999 20,867 108 98.2% 100.0% 100.0% 100.0%
Kenya 1999 30,040 199 94.5% 99.9% 100.0% 100.0%
Kenya 2009 12,193 54 99.2% 100.0% 100.0% 100.0%
Madagascar 2006 9,648 119 98.9% 100.0% 100.0% 100.0%
Mali Bougoula 2006 23,744 135 93.8% 99.9% 100.0% 100.0%
Mozambique - Manhica 2008 35,924 210 77.1% 99.8% 100.0% 100.0%
Nigeria - Afokang 2008 20,326 92 96.3% 99.7% 100.0% 100.0%
Nigeria - Pamol 2008 17,329 82 97.9% 99.8% 100.0% 100.0%
Senegal 1999 41,753 160 89.5% 99.8% 100.0% 100.0%
Senegal 2006 20,201 264 91.4% 99.7% 100.0% 100.0%
Uganda - Mbarara 2008 27,262 160 98.4% 100.0% 100.0% 100.0%
Zambia - Ndola 2008 35,887 85 91.9% 100.0% 100.0% 100.0%
Zanzibar Kivunge 2002 20,625 148 95.7% 100.0% 100.0% 100.0%
Zanzibar Micheweni 2002 18,236 54 95.2% 99.7% 100.0% 100.0%
Total 23,596 2355 93.9% 99.9% 100.0% 100.0%